Literature DB >> 9866246

[Pharmacology of local anesthetics and clinical aspects of segmental blocking. II. Spinal anesthesia].

S P Kozlov, V A Svetlov, M V Luk'ianov.   

Abstract

Clinical picture of development of segmental blocking after subarachnoidal injection of hyperbaric solutions of 0.75% bupivacaine, 5% ultracaine, and isobaric 0.5% bupivacaine is studied. A total of 152 patients operated on the lower part of the body and the lower limbs were examined under conditions of single, prolonged subarachnoidal, and combined spinal epidural anesthesia. Ultracaine and bupivacaine in different concentrations with different barism provided anesthesia equivalent by the efficacy, depth, and dissemination of sensory block. Segmental blocking with 5% ultracaine was characterized by the shortest latent period (3.14 +/- 0.16 min, p < 0.05) but was no shorter (124.1 +/- 3.37 min) than operative analgesia with 0.75% hyperbaric bupivacaine (120.0 +/- 5.10 min). Isobaric bupivacaine provided the longest effective analgesia (215.0 +/- 45.0 min, p < 0.05). Microcatheter technique improved the safety and control of subarachnoidal anesthesia in comparison with a single injection, and combined spinal epidural anesthesia shortened the latent period of segmental blocking and ensured intraoperative anesthesia and postoperative analgesia at the expense of the epidural component.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9866246

Source DB:  PubMed          Journal:  Anesteziol Reanimatol        ISSN: 0201-7563


  3 in total

1.  Allergic reaction in the use of primacaine adrenaline.

Authors:  Hui Xia He; Lin Feng; Hong Chen Liu
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

2.  Articaine: a review of its use for local and regional anesthesia.

Authors:  Marc Snoeck
Journal:  Local Reg Anesth       Date:  2012-06-05

3.  Use of Articaine in loco-regional anesthesia for day care surgical procedures.

Authors:  Sukhminder Jit Singh Bajwa; Ravi Jindal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.